氢化大豆磷脂作为稀释剂的应用：茶碱和双氯芬酸钠缓释片的制备 - Suppr | 超能文献

Use of hydrogenated soya phospholipids as a diluent: preparation of sustained-release tablets of theophylline and sodium diclofenac.

作者信息

Nishihata T, Nakano Y, Yamazaki M

出版信息

Chem Pharm Bull (Tokyo). 1987 Oct;35(10):4271-6. doi: 10.1248/cpb.35.4271.

DOI:10.1248/cpb.35.4271

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Use of hydrogenated soya phospholipids as a diluent: preparation of sustained-release tablets of theophylline and sodium diclofenac.氢化大豆磷脂作为稀释剂的应用：茶碱和双氯芬酸钠缓释片的制备

Chem Pharm Bull (Tokyo). 1987 Oct;35(10):4271-6. doi: 10.1248/cpb.35.4271.

2

Rat percutaneous transport of diclofenac and influence of hydrogenated soya phospholipids.双氯芬酸在大鼠体内的经皮转运及氢化大豆磷脂的影响。

Chem Pharm Bull (Tokyo). 1987 Sep;35(9):3807-12. doi: 10.1248/cpb.35.3807.

3

A comparative study of controlled release matrix tablets of diclofenac sodium, ciprofloxacin hydrochloride, and theophylline.双氯芬酸钠、盐酸环丙沙星和茶碱控释骨架片的对比研究

Drug Deliv. 2001 Jul-Aug;8(3):149-54. doi: 10.1080/107175401316906919.

4

Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.使用PVP-K90和天然胶体制备双氯芬酸钠缓释骨架片并进行体外-体内评价

Pak J Pharm Sci. 2011 Oct;24(4):435-43.

5

Per-oral controlled release dosage form of theophylline using soybean protein.使用大豆蛋白的茶碱口服控释剂型。

Drug Des Deliv. 1987 Feb;1(3):187-92.

6

Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium.用于双氯芬酸钠缓释的Compritol 888 ATO基质片剂的制备与表征

Pharm Dev Technol. 2015 Jun;20(4):507-12. doi: 10.3109/10837450.2013.871035. Epub 2013 Dec 20.

7

Formulation and in vivo evaluation of diclofenac sodium sustained release matrix tablet: effect of compression force.双氯芬酸钠缓释骨架片的处方设计与体内评价：压力的影响

Pak J Pharm Sci. 2015 Mar;28(2):573-9.

8

Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.双氯芬酸钠多源缓释片——溶出曲线的对比研究

J Pharm Biomed Anal. 2005 Apr 1;37(4):679-85. doi: 10.1016/j.jpba.2004.11.041. Epub 2004 Dec 22.

9

In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.一步熔融制粒法制备的两种新的缓控释制剂的体内评价：A级体外-体内相关性。

Eur J Pharm Biopharm. 2010 Jun;75(2):232-7. doi: 10.1016/j.ejpb.2010.02.008. Epub 2010 Feb 14.

10

Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.控释茶碱片的设计与评价。初步交流

Farmaco. 1989 Nov;44(11):1119-26.